Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Avro Life Science
AddedMar 20, 2024
UpdatedJul 7, 2026
Avro Life Science

Avro Life Science

Seed

Avro Life Science is a drug-delivery biotech that develops transdermal skin patches for generic drugs.

Accelerator
Y Combinator logoY CombinatorW18
Overview
Compare
Fundraising
Employees
Website

The company develops transdermal skin patches, including medicated stickers for children, that deliver generic drugs through the skin instead of oral pills. Its polymer-based patch technology releases drugs at a steady rate and is designed to address poor oral bioavailability and pill-swallowing difficulties, particularly among children and older adults.

Avro Life Science serves patients with seasonal allergies and other conditions requiring chronic medication, along with pharmaceutical companies seeking alternative delivery formats for generic or failed oral drugs. It operates in the drug delivery and biotech sectors, competing with transdermal patch developers and specialty pharmaceutical companies, and is positioned as a platform technology provider rather than a single-product drugmaker.

Avro Life Science - Similar Companies

Avro Life Science logo

Avro Life Science

Avior Bio logo

Avior Bio

Syntis Bio logo

Syntis Bio

syntis.bio

Aktivax logo

Aktivax

aktivax.com

Toralgen logo

Toralgen

toralgen.com

Vascarta logo

Vascarta

vascarta.com

Prometheon Pharma logo

Prometheon Pharma

ParcelBio logo

ParcelBio

parcelbio.com

Intact Therapeutics logo

Intact Therapeutics

SkinJect logo

SkinJect

skinjectpatch.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Outplay logo

Outplay

outplayinc.com

Alltranz logo

Alltranz

alltranz.com.au

Keylika logo

Keylika

keylika.com

Iontera logo

Iontera

Avro Life Science - Quick Facts

Who are Avro Life Science's competitors?

Companies similar to Avro Life Science include Avro Life Science, Avior Bio, Syntis Bio and Aktivax.

When was Avro Life Science's last funding round?

Avro Life Science's most recent funding round was for $120k (USD) in January 2018.

How much has Avro Life Science raised to-date?

As of Jan 1, 2018, Avro Life Science has raised a total of $120k (USD).

How many employees does Avro Life Science have?

Avro Life Science has 8 employees as of Aug 23, 2023.